[1]郝伟远,陈玉堂,林 婧,等.DSA引导下改良股静脉植入输液港术式在恶性肿瘤患者中的应用[J].介入放射学杂志,2021,30(08):780-783.
 HAO Weiyuan,CHEN Yutang,LIN Jing,et al.Application of DSA-guided modified implantation technique of infusion port via femoral vein in treating patients with malignant tumors[J].journal interventional radiology,2021,30(08):780-783.
点击复制

DSA引导下改良股静脉植入输液港术式在恶性肿瘤患者中的应用()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
30
期数:
2021年08
页码:
780-783
栏目:
肿瘤介入
出版日期:
2021-08-25

文章信息/Info

Title:
Application of DSA-guided modified implantation technique of infusion port via femoral vein in treating patients with malignant tumors
作者:
郝伟远 陈玉堂 林 婧 郑家平 邵国良
Author(s):
HAO Weiyuan CHEN Yutang LIN Jing ZHENG Jiaping SHAO Guoliang.
Institute of Cancer and Basic Medicine, Chinese Academy of Sciences; Affiliated Cancer Hospital of the University of Chinese Academy of Sciences; Department of Interventional Therapy of Zhejiang Provincial Cancer Hospital, Hangzhou, Zhejiang Province 310022, China
关键词:
【关键词】 股静脉 输液港 恶性肿瘤
文献标志码:
A
摘要:
【摘要】 目的 探讨DSA引导下经股静脉植入输液港改良术式在恶性肿瘤患者中的应用的安全性、技术可行性及相关并发症。 方法 选择2014年2月至2020年1月26例接受DSA引导下改良股静脉植入输液港术式的恶性肿瘤患者,采用Seldinger技术穿刺右侧股静脉,于右下腹壁植入静脉输液港。所有患者进行随访,随访终点为输液港移除或患者死亡。 结果 26例患者植入均获成功,术中无并发症发生,平均手术时间(22.1±6.9) min。10例术中出现导管异位至对侧髂静脉或腰静脉,在DSA下调整后均成功进入下腔静脉主干,导管头端位于下腔静脉位置:10例位于腰2椎体水平,11例位于腰3椎体水平,5例位于腰4椎体水平。随访780个导管日,共发生4例并发症,其中1例为纤维蛋白鞘形成,1例为囊袋感染破溃,1例为导管卷曲异位至皮下,1例为导管于腹股沟处打折致输液不畅,其中3例致非计划拔管。26例患者均未发生深静脉血栓形成、相关肢体运动受限及不适感等并发症。无相关死亡事件发生。 结论 对于无法植入胸壁输液港的患者,在DSA引导下行改良经股静脉植入输液港术式是安全可行的,并发症发生率低。

参考文献/References:

[1] Niederhuber JE, Ensminger W, Gyves JW,et al. Central venous access devices and approach to selection in adults[J]. Surgery, 1982, 92: 706-712.
[2] Ding XY, Ding F, Wang YG, et al. Shanghai expert consensus on totally implantable access ports 2019[J]. J Intervent Med, 2019, 2: 141-145.
[3] Kato K, Iwasaki Y, Onodera K,et al. Totally implantable venous access port via the femoral vein in a femoral port position with CT-venography[J]. J Surg Oncol, 2016, 114: 1024-1028.
[4] Almasi-Sperling V, Hieber S, Lermann J, et al. Femoral placement of totally implantable venous access ports in patients with bilateral breast cancer[J]. Geburtshilfe Frauenheilkd, 2016, 76: 53-58.
[5] Kondo T, Matsumoto S, Doi K, et al. Femoral placement of a totally implantable venous access port with spontaneous catheter fracture: case report[J]. CVIR Endovasc, 2020, 3:2.
[6] Chen SY, Lin CH, Chang HM, et al. A safe and effective method to implant a totally implantable access port in patients with synchronous bilateral mastectomies: modified femoral vein approach[J]. J Surg Oncol, 2008, 98: 197-199.
[7] 赵林芳,曾旭芬,王雅萍,等. 经大腿中段股静脉留置PICC在78例患者中的应用[J]. 中华护理杂志, 2018, 53:1089-1092.
[8] Wolosker N, Yazbek G, Munia MA, et al. Totally implantable femoral vein catheters in cancer patients[J]. Eur J Surg Oncol, 2004, 30: 771-775.
[9] 丁 伟,周 奇,孙飞虎,等. 完全植入式静脉输液港术后港体翻转临床分析[J]. 介入放射学杂志, 2020, 29:291-295.

相似文献/References:

[1]姜广伟,唐雷,吕柏楠.股总动脉医源性损伤1例 [J].介入放射学杂志,2020,29(02):179.
 JIANG Guangwei,TANG Lei,LÜ,et al.Iatrogenic injury of common femoral artery caused by femoral vein puncture: report of one case[J].journal interventional radiology,2020,29(08):179.
[2]郭新春,徐新建,任冬青,等.DSA引导下颈内、锁骨下及腋静脉入路输液港的临床应用[J].介入放射学杂志,2023,32(12):1211.
 GUO Xinchun,XU Xinjian,REN Dongqing,et al.Clinical application of DSA-guided infusion port implantation via internal jugular vein, subclavian vein and axillary vein[J].journal interventional radiology,2023,32(08):1211.
[3]金光鑫,张芳琴,王雅雯,等.超声联合DSA引导下经上臂静脉输液港植入术在恶性肿瘤化疗患者中的临床应用研究 [J].介入放射学杂志,2024,33(07):733.
 JIN Guangxin,ZHANG Fangqin,WANG Yawen,et al.Clinical application of ultrasound combined with DSA-guided implantation of totally implantable venous access port via upper arm vein approach in chemotherapy for patients with malignant tumors[J].journal interventional radiology,2024,33(08):733.
[4]高佩,钱火红,谢明晖,等.成人输液港置入与维护的最佳证据[J].介入放射学杂志,2024,33(08):902.
 GAO Pei,QIAN Huohong,XIE Minghui,et al.Summary of the best evidences for the placement and maintenance of adult infusion ports[J].journal interventional radiology,2024,33(08):902.

备注/Memo

备注/Memo:
(收稿日期:2020-09-02)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2021-08-18